| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | DE4425781A1 Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel Technetium-sulfonamide complexes, their use, pharmaceutical compositions containing them, and processes for producing the complexes and agents |
| 01/18/1996 | DE4425778A1 Komplexverbindungen zur Diagnose von Gefäßerkrankungen Complexes for the diagnosis of vascular disease |
| 01/17/1996 | EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 01/17/1996 | EP0461193B1 Discrimination between antibodies against htlv-i, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484770 Peptide compounds which inhibit the proliferation of epidermal or epithelial stem cells |
| 01/16/1996 | US5484592 Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs |
| 01/11/1996 | WO1996000782A1 Stem cell immobilisation |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000503A1 Novel peptides |
| 01/11/1996 | CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691344A1 Purification of trehalose |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690875A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690723A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0563062B1 Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 01/09/1996 | US5482930 Anti-inflammatory composition and method with des-Tyr dynorphin and analogues |
| 01/04/1996 | WO1996000238A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | CA2193860A1 T cell epitopes of rye grass pollen allergen |
| 01/03/1996 | EP0440686B1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 01/02/1996 | US5480970 Radioactive materials for labels in diagnosis of tumors in tissues |
| 01/02/1996 | US5480969 Luteinizing hormone releasing hormone antagonists similar to antide and congeners with higher water solubility due to hydrophilic residue substitutions in positions 1, 5 or 6; antiovulatory activity with minimal histamine-releasing effect |
| 01/02/1996 | US5480870 Heptapeptide and octapeptide amide derivatives; treatment of excessive secretion of insulin, glucagon or growth hormone |
| 01/02/1996 | US5480868 Sustained-release preparation |
| 01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 01/02/1996 | CA1337891C Anf derivatives with novel bridging |
| 12/28/1995 | WO1995035376A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
| 12/28/1995 | WO1995035374A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 12/28/1995 | WO1995030009A3 Identification, production and use of saponin glyclosyl hydrolases |
| 12/28/1995 | CA2193526A1 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
| 12/27/1995 | EP0688789A1 Lipopeptid-derivatives, process for their preparation and their use |
| 12/27/1995 | EP0688360A1 Bone stimulating factor |
| 12/27/1995 | EP0688314A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 12/27/1995 | EP0580694A4 Production of phosphopeptides from casein |
| 12/27/1995 | EP0550650B1 Antagonists of human gamma interferon |
| 12/27/1995 | EP0502198B1 Novel polypeptide and anti-hiv drug prepared therefrom |
| 12/27/1995 | EP0268663B1 Phosphopeptides |
| 12/26/1995 | US5478810 Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors |
| 12/26/1995 | US5478809 Blood disorders |
| 12/26/1995 | US5478808 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
| 12/26/1995 | US5478741 Antibodies to the HRPII protein of plasmodium falciparum |
| 12/26/1995 | US5478726 Mixing sample containing human lymphocytes with stimulant culture containing antigen-producing cells and peptide antigen then maintaining culture until immune cells indicate stimulation, if present, kits for medical diagnosis |
| 12/26/1995 | CA1337840C Amides of teicoplanin compounds |
| 12/26/1995 | CA1337839C Synthesis of peptide amides by means of a solid phase method using acid-labile anchoring groups |
| 12/26/1995 | CA1337838C Aglycons of a/16686 antibiotics |
| 12/21/1995 | WO1995034817A1 Positive and positive/negative cell selection mediated by peptide release |
| 12/21/1995 | WO1995034577A1 Template directed cyclization |
| 12/21/1995 | WO1995034312A1 Constrained peptides |
| 12/21/1995 | CA2191479A1 Constrained peptides |
| 12/20/1995 | EP0687685A1 Physiologically active peptide |
| 12/20/1995 | EP0687270A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 12/20/1995 | EP0687182A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 12/20/1995 | EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 12/20/1995 | EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
| 12/19/1995 | US5476841 Peptide |
| 12/19/1995 | US5476840 Hypotensive agents |
| 12/19/1995 | CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation |
| 12/19/1995 | CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation |
| 12/19/1995 | CA1337758C Peptide antibiotics |
| 12/14/1995 | WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 12/14/1995 | WO1995033850A1 Toxin assay |
| 12/14/1995 | WO1995033823A1 Methods for selectively stimulating proliferation of t cells |
| 12/14/1995 | WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells |
| 12/14/1995 | WO1995033765A1 Conformationally constrained backbone cyclized peptide analog |
| 12/14/1995 | WO1995033496A1 Radiolabeled compounds for thrombus imaging |
| 12/14/1995 | WO1995028426A3 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 12/14/1995 | CA2192305A1 Conformationally constrained backbone cyclized peptide analogs |
| 12/14/1995 | CA2191949A1 Radiolabeled compounds for thrombus imaging |
| 12/14/1995 | CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 12/14/1995 | CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells |
| 12/14/1995 | CA2191586A1 Methods for selectively stimulating proliferation of t cells |
| 12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 12/12/1995 | US5475087 Polypeptides |
| 12/12/1995 | US5475085 Unlimited array of peptides having reverse turn mimetics |
| 12/07/1995 | WO1995033206A1 Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay |
| 12/07/1995 | WO1995032990A1 Cyclodepsipeptide |
| 12/07/1995 | WO1995032985A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 12/07/1995 | WO1995026980A3 Haptenated peptides and uses thereof |
| 12/07/1995 | WO1995025749A3 Eating suppressant peptides |
| 12/07/1995 | CA2191430A1 Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay |
| 12/07/1995 | CA2190982A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 12/06/1995 | EP0685224A1 Cosmetic sunscreening compositions containing a synergic mixture of filters and nanopigments and uses |
| 12/06/1995 | EP0684843A1 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING |
| 12/06/1995 | EP0409962B1 Agent for inhibiting hiv-proteases |
| 12/06/1995 | CN1112933A Antigen-specific, activated T lymphocytes, detection and use |
| 12/06/1995 | CN1112931A Schistosome vaccine peptide No.3 |
| 12/06/1995 | CN1112930A Schistosome vaccine peptide No.2 |
| 12/06/1995 | CN1112929A Schistosome vaccine peptide No.1 |
| 12/05/1995 | US5473052 Antigen-binding fragments of an antibody to type-I collagen amino-terminal telopeptide |
| 12/05/1995 | US5473051 Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs |
| 12/05/1995 | US5472945 Modulation of blood pressure and inhibition of platelet activation with kininogen fragment |
| 12/05/1995 | US5472942 Anti-thrombins |
| 12/05/1995 | US5472884 To determine rate of bone resorption; quantitating crosslinked collagen telopeptides in control and test samples and in vivo; kits; detecting osteoporosis |
| 12/05/1995 | US5472841 Methods for identifying nucleic acid ligands of human neutrophil elastase |